Search

Your search keyword '"Vinci, M."' showing total 819 results

Search Constraints

Start Over You searched for: Author "Vinci, M." Remove constraint Author: "Vinci, M."
819 results on '"Vinci, M."'

Search Results

2. Two siblings affected by Netherton/Comèl syndrome. Diagnostic pathology and description of a new SPINK5 variant

6. Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid

7. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

8. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections

9. Guidance on the monitoring of marine litter in European seas – An update to improve the harmonised monitoring of marine litter under the Marine Strategy Framework Directive.

10. CISN ShakeAlert: An Earthquake Early Warning Demonstration System for California

12. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

13. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

14. Real-world experience with obeticholic acid in patients with primary biliary cholangitis

15. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

16. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

17. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

18. High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

19. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

21. Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

22. Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

23. Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort

25. Liraglutide Preserves CD34+ Stem Cells from Dysfunction Induced by High Glucose Exposure

26. Exome sequencing in a child with neurodevelopmental disorder and epilepsy:variant analysis of the AHNAK2 gene

27. Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry

28. Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience

29. Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant

31. A cost-of-illness study of spina bifida in Italy

37. Infrared imaging of choroidal involvement in Leber’s idiopathic stellate neuroretinitis

38. High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

42. HepaDisk – A new quality of life questionnaire for HCV patients

43. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

44. Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

45. Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019

49. Tumor cell invasion into Matrigel: optimized protocol for RNA extraction

50. Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse

Catalog

Books, media, physical & digital resources